Johnson & Johnson (JNJ) financials
Healthcare · CIK 0000200406 · fiscal years FY2021–FY2025
In fiscal year 2025 (ending Dec 2025), Johnson & Johnson (JNJ) reported $94.19B in revenue and $26.80B in net income, a net profit margin of 28.5%. Revenue changed +6.0% versus FY2024. Over FY2021–FY2025, revenue grew at a 3.3% compound annual rate. All figures are from Johnson & Johnson's SEC 10-K filings.
Source: SEC EDGAR, CIK 0000200406. Data as of 2026-06-18.
Key ratios (FY2025)
| Metric | Value | Basis |
|---|---|---|
| Net profit margin | 28.5% | Net income ÷ revenue |
| Operating margin | — | Operating income ÷ revenue |
| R&D intensity | 0.1% | R&D expense ÷ revenue |
| Revenue YoY growth | +6.0% | vs FY2024 |
| Revenue CAGR (4y) | 3.3% | FY2021 → FY2025 |
Source: SEC EDGAR. Data as of 2026-06-18.
Annual financials by fiscal year
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $82.58B | $20.00B | $85.16B | $88.82B | $94.19B |
| Net income | $14.71B | $4.46B | $35.15B | $14.07B | $26.80B |
| Operating income | — | — | — | — | — |
| R&D expense | — | $0 | $483.0M | $1.84B | $109.0M |
| Total assets | $174.89B | $182.02B | $167.56B | $180.10B | $199.21B |
| Total liabilities | $111.62B | $108.00B | $98.78B | $108.61B | $117.67B |
| Shareholders' equity | — | — | — | — | — |
| Cash & equivalents | $13.98B | $14.49B | $21.86B | $24.11B | $19.71B |
| Diluted EPS | 5.51 | 1.68 | 13.72 | 5.79 | 11.03 |
| Revenue YoY growth | — | −75.8% | +325.9% | +4.3% | +6.0% |
Source: SEC EDGAR — Johnson & Johnson 10-K filings (CIK 0000200406). Data as of 2026-06-18. Revenue concept: RevenueFromContractWithCustomerExcludingAssessedTax.
How to read these figures
Revenue is the top line; operating income is profit from core operations before interest and tax; net income is the bottom line after every expense. The profit-margin calculator turns these into margins, and the revenue CAGR calculator annualises multi-year growth. For background, see revenue vs operating income vs net income and how to read a 10-K.
Frequently asked questions
What was Johnson & Johnson's revenue in FY2025?
Johnson & Johnson reported $94.19B in revenue for fiscal year 2025 (period ending Dec 2025), per its SEC 10-K filing. That is +6.0% versus FY2024.
What is Johnson & Johnson's net profit margin?
In FY2025, Johnson & Johnson earned $26.80B of net income on $94.19B of revenue — a net profit margin of 28.5%.
How fast has Johnson & Johnson's revenue grown?
Between FY2021 and FY2025, Johnson & Johnson's revenue grew at a compound annual rate (CAGR) of 3.3%.
Where does this Johnson & Johnson financial data come from?
All figures are taken from Johnson & Johnson's annual 10-K filings on SEC EDGAR (CIK 0000200406), via the SEC XBRL company facts API. They are factual data, not investment advice — verify on SEC EDGAR before relying on them.
Source & verification
Figures are taken from Johnson & Johnson's annual 10-K filings on SEC EDGAR (CIK 0000200406), via the EDGAR XBRL company facts API. They are factual data compiled from SEC filings — not investment advice; figures may contain errors or lag the original filing. Verify on SEC EDGAR before relying on them.
Last updated: 2026-06-18